MedTrace Logo

Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?

NCT02903082 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 68

Last updated 2019-01-28

No results posted yet for this study

Summary

Sepsis remains a major cause of death in developed countries. A better understanding of the mechanisms involved in the regulation of inflammatory and immune response of patients with severe sepsis is an important step that could open the way for new therapeutic approaches.

Conditions

  • Severe Sepsis
  • Inflammatory Response Syndrome, Systemic

Interventions

BIOLOGICAL

Residue of blood further to NFS

BIOLOGICAL

Residue of blood further to preoperative workup

BIOLOGICAL

Bone marrow collected during a myelogram carried out for hematological pathology workup

BIOLOGICAL

Bone marrow collected during myelogram routinely performed during hospitalization in ICU

Sponsors & Collaborators

  • University Hospital, Limoges

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02903082 on ClinicalTrials.gov